(Q36621967)

15 August 2017

title

Adaptive dose selection using efficacy-toxicity trade-offs: illustrations and practical considerations (English)

1 reference

15 August 2017

Peter F Thall

1

1 reference

15 August 2017

John D Cook

series ordinal

2

1 reference

15 August 2017

Elihu H Estey

series ordinal

3

1 reference

15 August 2017

publication date

1 January 2006

1 reference

Journal of Biopharmaceutical Statistics

15 August 2017

published in

1 reference

15 August 2017

volume

16

1 reference

15 August 2017

issue

5

1 reference

15 August 2017

page(s)

623-638

1 reference

A Bayesian approach to jointly modeling toxicity and biomarker expression in a phase I/II dose-finding trial

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10543400600860394

The bivariate continual reassessment method. extending the CRM to phase I trials of two competing outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10543400600860394

Simulation as a design tool for phase I/II clinical trials: an example from bone marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10543400600860394

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10543400600860394

Dose-finding based on efficacy-toxicity trade-offs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10543400600860394

10.1080/10543400600860394

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference